Tag: France

The Future Of The Home Healthcare Equipment Market To 2016 – Market Forecasts, Competitive Landscape

Posted on by admin

Browse Complete Report: Home Healthcare Market

GBI Researchs report, The Future of the Home Healthcare Equipment Market to 2016 – Increasing Awareness Driving Demand provides key data, information and analysis on the global home healthcare equipment market. The report provides market landscape, competitive landscape and market trends information on seven home healthcare equipment market segments glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope
Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
Market size and company share data for seven home healthcare equipment market categories glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring.
Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008
Qualitative analysis of key market trends, market drivers, and restraints by each category within the home healthcare equipment market.
The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Reasons to buy
Develop business strategies by understanding the trends and developments that are driving the home healthcare equipment market globally.
Design and develop your product development, marketing and sales strategies.
Exploit M&A opportunities by identifying market players with the most innovative pipeline.
Develop market-entry and market expansion strategies.
Identify key players best positioned to take advantage of the emerging market pportunities.
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
Whats the next being thing in the home healthcare equipment market landscape? Identify, understand and capitalize.
Make more informed business decisions from the insightful and in-depth analysis of the global home healthcare equipment market and the factors shaping it.

Buy Now: Market Research
Browse All: Home Healthcare Market

Related Reports:
Technologies for Long-Term Care and Home Healthcare: Global Markets
US Home Healthcare Equipment & Services Market: An Analysis
Home Healthcare Market (2009-2014) updated

Medicine In The Middle Ages

Posted on by admin

Learning is a continuing process and through new discoveries and invention we broaden our horizon of knowledge everyday. Throughout history man has illuminated the world with art, science, and philosophy and has also acquired abilities to invent and discover, various tools for its survival. One of the most powerful discoveries ever made is the knowledge of medicine. Though history of medicine can be traced back to the primitive age, medicine as a specialized field of study did not exit before the middle Ages. Based on Greek and eastern principles, European medicine embellished with the discoveries of the middle ages and set the foundation for the contemporary medicine.

The Heptameron by Marguerite de Navarre is a representation of the French society in the middle ages. She has depicted various social and cultural norms of the time in the stories. Her insight into the science of medical practiced in France in the Middle Ages is quite apparent Even though the importance of medicine as specialty was acknowledged among the intellectuals of Paris; the influence of the church remained a conduit for its advancement. Although the supremacy of supernatural over natural was obvious, a clear implication was established that the natural and supernatural world was separate if not independent. As a result what we see is an amalgamation of medical science, mysticism and religion in the middle age France.

Ancient physiologists believed that the body must always have a balance of these humors, for imbalance will cause ailments. Diagnosis was based on examining sample of blood and also colors of skin, urine and feces.

Medical treatment by trained physicians rare and very expensive as a result the elite class could only afforded it. The uncertainty and unavailability of academic treatment left no choice for the general population, but to turn towards certain charms, special prayers and specific Christian rituals. Thirteen century Paris had only a half dozen doctors in public employ, with little time to spend on individual patients. Practice of medicine was not restricted to a certain sect of people rather clergy and laymen, men and women were all able to practice medicine.

The physician often compounded and dispensed drugs in addition to practicing medicine. And apothecary often engaged in medical practice as well as compounding and dispensing. It is evident from the stories in heptameron that the drugs made by apothecaries could be very lethal at times as they did not have the proper knowledge. Also personal hygiene was not an important factor for an apothecary, live alone the common people.

Diet was thought to be extremely important in the treatment of illness and prescriptions would cover the minutest of details for all sorts of conditions. The greatest general reliance was placed on broths, milk and eggs. Today the importance of diet in medical science is felt extensively. Nutrition as a special branch of study has emerged. Dietitians and nutritionist are there to help physicians in treating patients who needs special diets. Plants and herbs were used in the preparation of digestives, laxatives, emetics, diuretics, diaphoretics, styptics etc. Drugs remain to be the major form of treatments today but with the advanced technology, pharmacology has become one of the leading businesses.

Surgery a last resort advised by a physician but also it was only accessible to the wealthy. Surgery was known to be successful in cases of fistula, hemorrhoids, gangrene and cataracts. Bloodletting was one of the most common forms of surgery and was recommended for fever, inflammation, and a variety of disease condition and ironically for hemorrhages as well. There were three main methods of bloodletting during the middle ages: leeching, venesection and cupping. Among these leeching is still used, though rare as a medical procedure by some physicians. Leeching helps to reduce tissue congestion where arterial input is maintained but venous return is blocked or slowed leeches act as an extra vein to relieve a dangerous build-up of blood. As a result leech therapy is finding its way into numerous reconstructive surgeries such as digit and limb reattachment, skin graft procedure, scalp avulsions, and breast surgeries and even into effective treatment of periorbital hematomas. Anesthesia and pain relievers were available but some of the potions used were lethal in itself. For example the hemlock juice was used, and it could easily cause death.

The diseases that were very common in the Middle Ages were dysentery, jaundices pneumonia, influenza and common cold. This could be largely attributed to the living condition of that time. Rural people largely lived in a one-room structure with a central fire or hearth and a central roof with a small opening which allowed some of the smoke to escape. Homes were dark damp and cold, with minimum sunlight and poor air circulation, a perfect breeding place for germs and bacteria. The climatic conditions and life style of the time with no proper facilities contributed to the lack of personal hygiene as well. It further escalated with population growth in the towns and cities. Also due to lack of advanced techniques, patients often died due to excessive blood loss after a surgery. Today personal hygiene is considered to be a key factor to live a disease free life.

With the latest technologies available infant mortality has reduced and longevity of humans has increased tremendously compared to middle ages. As we benefit from the sophisticated technologies of medical science, it is imperative that we acknowledge the contribution of our predecessors. What we are enjoying today is the fruits from the trees whose seeds were planted by our ancestor.

The Drug Exemestane Can Prevent Breast Cancer Without Any Side Effects

Posted on by admin

Exemestane can prevent breast cancer, The drug has been in the domestic market. If the people without breast cancer take exemestane before can reduce 60% the risk of breast cancer. Exemestane is an effective steroidal aromatase inactivator with superior tolerability, safety and efficacy in the adjuvant, neo-adjuvant and metastatic therapy of breast cancer.

The price of exemestane price is very expensive, Each month to pay 300-400 US dollars to take the medicine. The drug has been shown that breast cancer can be prevented. There are two other drugs can also prevent breast cancer, one is tamoxifen and other is raloxifene Evista. The risk of breast cancer will be reduced by 50% if the women take tamoxifen for 5 years and the raloxifene Evista is 38%. Tamoxifen has been shown to reduce the recurrence of ER-positive breast cancer when used after primary treatment. About 500, 000 women in the United States take tamoxifen, which cuts in half the chances of a breast cancer recurrence. Breast Cancer Prevention Trial begins testing tamoxifen a cancer treatment drug as a preventive agent in women at increased risk of the disease. For those who find out that they are at higher risk, the drugs tamoxifen and raloxifene may be options for lowering their risk.

However, these two drugs has the risk of uterine cancer and blood clots, Both teriparatide and raloxifene can significantly reduce the occurrence of new adjacent and nonadjacent vertebral fractures. some antidepressants and other medicines can lower the amount of tamoxifen’s active form in the bloodstream. Despite this risk, tamoxifen and another drug in this class, raloxifene, remain an extensively used and popular treatment. Although women may get the health from two new drugs, 4% of women taking these two drugs. Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis. Exemestane has no side effects than either drug. Subjects were 4560 postmenopausal women from Canada, the United States, France and Spain. Half of them taking exemestane, After three years, researchers found that only 11 of these people who suffer from breast cancer, without taking the drug have 32 people suffering from breast cancer.

Dr. Pierre Dupont Has Experience In Dental Business Management

Posted on by admin

Pierre Dupont DDS has more than a ten year experience in public dental education. He is the producer and host of sixty educative dental health talk-shows and television programs. He is the author of several newspaper articles and lecturer at several educative conferences and presentations for the public. He lectured for numerous associations of dental surgeons and denturists in Canada, France, Asia and South America. He is also the author of Dental Implants, an Illustrated Guide to Dental Implants and the Possibilities They Offer.

A seasoned dental professional, Dr Pierre Dupont dentist has more than twenty years of clinical practice experience. He had been dedicated to providing adults with complete oral rehabilitation including oral implantology, fixed and removable prosthodontics, orthodontics, periodontics, endodontics and aesthetic/general dentistry. He worked in collaboration with a network of 150 dental practitioners and denturists in Quebec and Ontario, giving lectures and on-site coaching in oral implant surgery and prosthodontics and in practice development.

Pierre Dupont dental surgeon has served as a Scientific Consultant for the quarterly oral implantology journal, Implantodontie, France. He was on staff at the “Socit Franaise des Biomatriaux et Systmes Implantables” (S.F.B.S.I), in the program for the Degree in Biomaterials and Implant Systems offered by Universit de Bordeaux II, France. He has been associated with several professional associations. From 1981-2003, he was member of the Ordre des dentistes du Qubec. He has membership of the International Association for Orthodontics, Academy of Osseointegration and Canadian Society of Oral Implantology. He was a fellow of the Academy of General Dentistry and of the International Congress of Oral Implantologists.

Pierre Dupont dentist has extensive educational background. He did his Doctorate in Dental Medicine from Universit Laval Qubec from 1977-1981. He received certificate in orthodontic studies from International Association for Orthodontics Montral and certificate in implant surgery and prosthodontics from Brnemark Clinic Gteborg. He went to Universit de Bordeaux II to receive degree in biomaterials and implant systems, and Misch Implant Institute to earn certificate in implant surgery and prosthodontics. He is also the holder of certificate in implant surgery and bone surgery from the Universit de Lille, France. He has earned a respectable name in the medical sector.

Will The President’s Job Bill Hurt Healthcare Jobs

Posted on by admin

In light of President Obama’s recent speech outlining his plan to create jobs, critics on both sides of the isle question whether or not his plan will be helpful or harmful. Even in unlikely sectors like health care, there is speculation that the Obama bill could be a job killing one. According to industry experts, health care is one of the few sectors that have continued to add jobs despite a persistent economic downturn – about 74,000 in 2010. The problem with the Obama bill is its effect on Medicare and Medicaid.

Impact of Cuts on Healthcare Jobs

Of the previously mentioned is 74,000 healthcare jobs added last year, almost 40% were in the field of assisted living. It is a field which accounts for a fair amount of growth in the overall industry as the American population continues to age. Unfortunately, the vast majority of patients who utilize assisted living do so on Medicare and Medicaid dollars. If the President’s plan is successful in cutting spending for Medicare and Medicaid programs, it could jeopardize the health of many assisted living facilities to the point that they will be forced to close.

Causing further concern is the implementation of universal healthcare beginning in 2014. That law, which was signed back in 2010, may also result in drastic cuts in government medical spending. Hospitals all over the country that depend on government funding for a variety of purposes will have to realign their budgets, forcing them to reduce their workforces. It seems as though a perfect storm may be on the horizon that could spell disaster for the healthcare industry.

The Other Side of the Story

On the other hand, some healthcare industry officials don’t believe the jobs bill will have an effect on healthcare jobs – even if Medicare and Medicaid are cut drastically. They cite the fact that people still need healthcare services, whether or not the government helps them pay for them. Resourceful Americans will find a way to get their healthcare and to make sure it’s paid for. And even in cases when that’s not possible, we are not a nation that allows our people to suffer unnecessarily. As long as there are people, there will be healthcare jobs.

Those who take this view point to countries like Germany and France where governments have realized they need to stop spending so much on healthcare. As a result, private enterprises have begun to spring up to fill in the gaps. And they are hiring.

Despite the potentially bumpy road ahead, health care facilities are continuing to add jobs. As mentioned previously, healthcare is one of the few industries that have continued to grow over the last couple of years, and statistics from the federal labor department indicate that the need for workers will only continue to grow over the next 5 to 10 years. Healthcare jobs will always be available; the only question is what types of jobs they will be. Only time will tell.

Some Myths about Federal Health Care Reform or Obamacare.

Posted on by admin

When the Patient Protection and Affordable Care Act (PPACA, aka ACA) became federal law in March of 2010, there were many assumptions about what the law would and would not do. As everyone knows, it has become known simply as “Obamacare,” because President Obama was the one who wanted health care reform. Here are some misconceptions about health care reform.

One of the first statements made was that the new law was tantamount to “a government takeover of healthcare.” For this to be true, the government would need to inform every citizen that they were being enrolled in a federal healthcare program, sort of like Medicare, which is a federal health care program for any qualifying citizen or permanent resident over the age of 65. In fact, there is no federal alternative to private health insurance today. Since most if not all health insurance companies that were doing business in 2010 are still insuring millions of policyholders today, it is safe to say that there has not been a government takeover of healthcare. It is also true however, that many people would like to see that happen. They would love to see Medicare expanded to include everyone; but that is very unlikely for many years to come, if ever.

“Medicare benefits will be reduced.” Actually the opposite has happened. Medicare now covers annual physical exams and colonoscopies in addition to the quite comprehensive benefits they have long provided. It is true that premium costs to Medicare beneficiaries will go up in future years, but medical costs and premiums have been rising steadily for decades, and seniors do use more medical services than people under 65.

There will be government “death panels” that will make end-of-life decisions for people on Medicare. This idea was borne out of a well-intended provision in the health care bill that would have helped pay for the end-of-life planning discussion cost that the elderly already have with their physicians and caregivers. So a good thing became a bad thing. Now there can be no provisions in Medicare for this benefit which, ironically, hurts seniors and can actually adds to the cost of health care.

Illegal immigrants will now be covered. The ACA specifically prohibits undocumented immigrants from receiving coverage.

What is not known is the true long-term cost of this legislation. There are many people on both sides of the argument, time will tell what the real cost will be, and there are many components of this program still to be implemented. The truth about health care is that it is expensive no matter where you are. Canada, England, France, Switzerland, Italy, China.

All of these countries have some form of government provided health care and while it is less expensive per-capita than in the United States, it is expensive nonetheless. The common element of all health care programs is that every citizen or legal permanent resident is covered. The cost of care per person is far lower when everyone is covered.
What needs to be understood about health care is that every person at some point will seek it out when they need it. Whether or not they have health insurance is not a factor when there is a need for treatment. If a person cannot afford car insurance they have the option of not driving, and few people drive without car insurance. Not so with health insurance, and the situation is made worse by the fact that uninsured people often ignore minor medical issues because of the cost. Unfortunately those minor medical issues have a way of becoming serious, and that is when the uninsured seek care. And where do they go to get treatment then? The emergency room, which happens to be the most expensive entry point into the entire health care system in the U.S. They go there because federal law prohibits hospitals from turning away anyone during a medical emergency.

This is a huge factor in the cost of health insurance, and a major reason why health insurance premiums have risen far in excess of the CPI over the past 30 years. Until that part of the health insurance equation is resolved the cost of insurance will continue to be out of reach for millions of Americans.

In summary, the cost of delivering health care in the U.S. is not going to go away as an issue. The debate over the number of uninsured and whether or not they should be covered, public vs. private insurance, and who pays for all of this will go on until our politicians realize that there is no one best solution. All sides will have to agree that there will always be some elements of a common health care system that not everyone will like. There are many elements of the Affordable Care Act which work, and those elements need to be preserved. Many insurers who initially opposed the Act have since re-tooled their benefit and pricing models to reflect the major objectives of the program. The irony here is that abolishing the ACA would actually increase the cost of coverage as insurers once again had to redesign their policies and coverage. What is needed most of all is a system that works reasonably well and covers everyone or nearly everyone. In the long run, the cost of excluding millions of uninsured will cost more than covering them.

Exemestane Has Mild Side Effects Can Prevent Breast Cancer

Posted on by admin

Exemestane has a good tolerability, has mild side effects. The Common side-effects including hot flashes, nausea, insomnia, depression, headaches, dizziness, pain, rash, abdominal pain, anorexia, vomiting, depression, hair loss, body or lower extremity edema, constipation and indigestion. Exemestane is an effective steroidal aromatase inactivator with superior tolerability, safety and efficacy in the adjuvant, neo-adjuvant and metastatic therapy of breast cancer. Exemestane is used for adjuvant treatment after tamoxifen treatment. The post-menopausal women patients with advanced breast cancer can accept such treatment.

Clinical trials show that the standard dose of exemestane is 25mg daily, There are 7.4% of patients give up treatment because of side effects In an interview with tamoxifen and exemestane adjuvant treatment of early breast cancer patients. The most commonly reported adverse reactions were hot flashes (22%), arthralgia (18%) and fatigue (16%). There are 2.8% of the patients appear side effects In all patients with advanced breast cancer. The most commonly reported adverse reactions were hot flashes (14%) and nausea (12%). Most Exemestane side effects is a normal pharmacology response (hot flushes), Because estrogen is blocked. Exemestane treatment for advanced breast cancer patients Rare with thrombocytopenia or leukopenia report. There are 20% of patients with episodic lymphopenia, Particularly past history of lymphopenia, but these patients had no symptoms of viral infection. There is no Exemestane side effect report in the treatment of early breast cancer.

Overall, exemestane has a good tolerability, with mild to moderate side effects. In the IES study, The rate of patients discontinued treatment is 6.3% of exemestane, Tamoxifen group was 5.1%. Although women may get the health from two new drugs, 4% of women taking these two drugs. Exemestane has no side effects than either drug. Subjects were 4560 postmenopausal women from Canada, the United States, France and Spain. Half of them taking exemestane, After three years, researchers found that only 11 of these people who suffer from breast cancer, without taking the drug have 32 people suffering from breast cancer. Exemestane can prevent breast cancer, The drug has been in the domestic market. If the people without breast cancer take exemestane before can reduce 60% the risk of breast cancer. Exemestane is an effective steroidal aromatase inactivator with superior tolerability, safety and efficacy in the adjuvant, neo-adjuvant and metastatic therapy of breast cancer.

© 2025 Force Health Care